Literature DB >> 16728685

Genetic analysis of familial connective tissue alterations associated with cervical artery dissections suggests locus heterogeneity.

Tina Wiest1, Sonja Hyrenbach, Pinar Bambul, Birgit Erker, Alessandro Pezzini, Ingrid Hausser, Marie-Luise Arnold, Juan José Martin, Stefan Engelter, Philippe Lyrer, Otto Busse, Tobias Brandt, Caspar Grond-Ginsbach.   

Abstract

BACKGROUND AND
PURPOSE: Cervical artery dissections (CAD) can be associated with connective tissue aberrations in skin biopsies. The analysis of healthy relatives of patients suggested that the connective tissue phenotype is familial with an autosomal dominant inheritance.
METHODS: We performed genetic linkage studies in 3 families of patients with CAD. Connective tissue phenotypes for the patients and all family members were assessed by electron microscopic study of skin biopsies. A genome-wide linkage analysis of 1 family (1 patient with 8 healthy relatives) indicated 2 candidate loci. Three genes were subsequently studied by sequence analysis. Part of the genome was also studied by linkage analysis in 2 further families.
RESULTS: The genome-wide scan in a single family suggested linkage between the hypothetical mutation causing the connective tissue phenotype and informative genetic markers on chromosome 15q24 (logarithm of the odds score: Z= +2.1). A second possible candidate locus (Z=+1.9) was found on chromosome 10q26. Sequence analysis of 3 candidate genes in the suggestive locus (chondroitin sulfate proteoglycan4 [CSPG4], lysyl oxidase-like1 [LOXL1] and fibroblast growth factor receptor2 [FGFR2]) did not lead to the identification of a mutation responsible for connective tissue alterations. In 2 additional smaller families the loci on chromosome 15q24 and 10q26 were excluded by linkage analysis.
CONCLUSIONS: Linkage analysis of a large family with CAD-associated connective tissue alterations suggested the presence of a candidate locus on chromosome 15q2 or on chromosome 10q26. Sequence analysis did not lead to the identification of a mutated candidate gene in 1 of these loci. The study of 2 additional pedigrees indicated locus heterogeneity for the connective tissue phenotype of CAD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728685     DOI: 10.1161/01.STR.0000226624.93519.78

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Identical Horner Syndrome in Homozygotic Twins Caused by Non-Traumatic Internal Carotid Artery Dissection.

Authors:  Per Kappelgaard; Frauke Wolfram; Steffen Hamann
Journal:  Neuroophthalmology       Date:  2018-10-22

2.  TGFBR2 mutation and MTHFR-C677T polymorphism in a Mexican mestizo population with cervico-cerebral artery dissection.

Authors:  Angélica Ruiz-Franco; Miguel A Barboza; Aurelio Jara-Prado; Samuel Canizales-Quinteros; Paola Leon-Mimila; Nayelli Arguelles-Morales; Juan-Camilo Vargas-González; Alejandro Quiroz-Compean; Antonio Arauz
Journal:  J Neurol       Date:  2016-03-26       Impact factor: 4.849

3.  Familial occurrence and heritable connective tissue disorders in cervical artery dissection.

Authors:  Stéphanie Debette; Barbara Goeggel Simonetti; Sabrina Schilling; Juan José Martin; Manja Kloss; Hakan Sarikaya; Ingrid Hausser; Stefan Engelter; Tiina M Metso; Alessandro Pezzini; Vincent Thijs; Emmanuel Touzé; Stefano Paolucci; Paolo Costa; Maria Sessa; Yves Samson; Yannick Béjot; Ayse Altintas; Antti J Metso; Dominique Hervé; Christoph Lichy; Simon Jung; Urs Fischer; Chantal Lamy; Armin Grau; Hugues Chabriat; Valeria Caso; Philippe A Lyrer; Christian Stapf; Turgut Tatlisumak; Tobias Brandt; Elisabeth Tournier-Lasserve; Dominique P Germain; Michael Frank; Ralf W Baumgartner; Caspar Grond-Ginsbach; Marie-Germaine Bousser; Didier Leys; Jean Dallongeville; Anna Bersano; Marcel Arnold
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

Review 4.  Cervical Artery Dissections: Etiopathogenesis and Management.

Authors:  Zafer Keser; Chia-Chun Chiang; John C Benson; Alessandro Pezzini; Giuseppe Lanzino
Journal:  Vasc Health Risk Manag       Date:  2022-09-02

Review 5.  Theranostic impact of NG2/CSPG4 proteoglycan in cancer.

Authors:  Pier Andrea Nicolosi; Alice Dallatomasina; Roberto Perris
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.